Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 8/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 8/20 | 0.68 |
| ▸ | MAPT | P10636 | 7/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.68 |
| ▸ | HTT | P42858 | 3/20 | 0.68 |
| ▸ | LMNA | P02545 | 2/20 | 0.68 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.68 |
| ▸ | POLB | P06746 | 2/20 | 0.68 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.54 |
| ▸ | NPC1 | O15118 | 4/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | RAB9A | P51151 | 4/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.51 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.51 |
| ▸ | RECQL | P46063 | 1/20 | 0.51 |
| ▸ | CASP3 | P42574 | 2/20 | 0.50 |
| ▸ | SENP8 | Q96LD8 | 2/20 | 0.50 |
| ▸ | SENP7 | Q9BQF6 | 2/20 | 0.50 |
| ▸ | SENP6 | Q9GZR1 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4278053 | 1.00 | MEN1 (0.68) | MEN1KMT2AMAPTALDH1A1HTT | |
| SCHEMBL4278058 | 1.00 | MEN1 (0.68) | MEN1KMT2AMAPTALDH1A1HTT | |
| SCHEMBL8827154 | 0.85 | MAPT (0.89) | MEN1KMT2AMAPTALDH1A1HTT | |
| SCHEMBL8827131 | 0.85 | MAPT (0.89) | MEN1KMT2AMAPTALDH1A1HTT | |
| SCHEMBL8556068 | 0.83 | MEN1 (0.57) | MEN1KMT2AMAPTALDH1A1HTT | |
| SCHEMBL1276291 | 0.83 | ALDH1A1 (0.68) | MEN1KMT2AMAPTALDH1A1HTT | |
| SCHEMBL31307193 | 0.83 | MEN1 (0.57) | MEN1KMT2AMAPTALDH1A1HTT | |
| SCHEMBL1276292 | 0.83 | ALDH1A1 (0.68) | MEN1KMT2AMAPTALDH1A1HTT | |
| SCHEMBL28002467 | 0.83 | MEN1 (0.59) | MEN1KMT2AMAPTALDH1A1HTT | |
| SCHEMBL10898315 | 0.83 | MEN1 (0.57) | MEN1KMT2AMAPTALDH1A1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090258429-A1 | Colorimetric detection of cyanide with a chromogenic oxazine | MIAMI, THE UNIVERSITY OF | 2009-10-15 | — | — | US | claimed |
| WO-2007028080-A1 | COLORIMETRIC DETECTION OF CYANIDE WITH A CHROMOGENIC OXAZINE | THE UNIVERSITY OF MIAMI (US) | 2007-03-08 | — | — | WO | claimed |
| WO-2026082575-A1 | SYNTHESIS OF STABLE ISOTOPE LABELED VERSIONS OF N-(4-HYDROXYPHENYL)ACETAMID | ROCHE DIAGNOSTICS GMBH (DE) | 2026-04-23 | — | — | WO | disclosed |
| US-20220404323-A1 | INDICATOR MATERIAL COMPRISING A POLYMERIC GEL CARRIER AND POLYMERIC INDICATOR | MOOW.FARM KFT. (HU) | 2022-12-22 | — | — | US | disclosed |
| US-8198436-B2 | Colorimetric detection of cyanide with a chromogenic oxazine | THE UNIVERSITY OF MIAMI (US) | 2012-06-12 | — | — | US | disclosed |
| US-20090258429-A1 | Colorimetric detection of cyanide with a chromogenic oxazine | MIAMI, THE UNIVERSITY OF | 2009-10-15 | — | — | US | disclosed |
| US-20080305047-A1 | Chemosensors Based on Quantum Dots and Oxazine Compounds | NATIONAL SCIENCE FOUNDATION | 2008-12-11 | — | — | US | disclosed |
| WO-2008018894-A2 | CHEMOSENSORS BASED ON QUANTUM DOTS AND OXAZINE COMPOUNDS | THE UNIVERSITY OF MIAMI (US) | 2008-02-14 | — | — | WO | disclosed |
| WO-2007028080-A1 | COLORIMETRIC DETECTION OF CYANIDE WITH A CHROMOGENIC OXAZINE | THE UNIVERSITY OF MIAMI (US) | 2007-03-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080305047-A1 | Chemosensors Based on Quantum Dots and Oxazine Compounds | OR51E2, CDYL, CDYL2 | MEN1 4457/4885KMT2A 4460/4885MAPT 2426/4885 |
| US-20090258429-A1 | Colorimetric detection of cyanide with a chromogenic oxazine | CBR3, CBR1, CYCS | MEN1 4062/4885KMT2A 3788/4885MAPT 4305/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.